Novo Nordisk A/S (NVO)
37.54
+0.22
(+0.59%)
USD |
NYSE |
Oct 05, 16:00
37.55
+0.01
(+0.03%)
After-Hours: 20:00
Novo Nordisk Market Cap : 125.60B for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 125.60B |
| October 02, 2026 | 124.87B |
| October 01, 2026 | 125.14B |
| September 30, 2026 | 126.84B |
| September 29, 2026 | 128.18B |
| September 28, 2026 | 129.52B |
| September 25, 2026 | 129.82B |
| September 24, 2026 | 129.22B |
| September 23, 2026 | 127.71B |
| September 22, 2026 | 131.83B |
| September 21, 2026 | 133.17B |
| September 18, 2026 | 144.68B |
| September 17, 2026 | 144.51B |
| September 16, 2026 | 139.56B |
| September 15, 2026 | 142.30B |
| September 14, 2026 | 145.38B |
| September 11, 2026 | 144.11B |
| September 10, 2026 | 147.25B |
| September 09, 2026 | 149.09B |
| September 08, 2026 | 151.10B |
| September 04, 2026 | 155.92B |
| September 03, 2026 | 158.96B |
| September 02, 2026 | 156.49B |
| September 01, 2026 | 150.97B |
| August 31, 2026 | 151.67B |
| Date | Value |
|---|---|
| August 28, 2026 | 152.61B |
| August 27, 2026 | 154.78B |
| August 26, 2026 | 157.89B |
| August 25, 2026 | 162.81B |
| August 24, 2026 | 156.99B |
| August 21, 2026 | 156.39B |
| August 20, 2026 | 154.38B |
| August 19, 2026 | 155.52B |
| August 18, 2026 | 152.94B |
| August 17, 2026 | 150.16B |
| August 14, 2026 | 153.54B |
| August 13, 2026 | 156.32B |
| August 12, 2026 | 155.22B |
| August 11, 2026 | 157.83B |
| August 10, 2026 | 159.70B |
| August 07, 2026 | 158.13B |
| August 06, 2026 | 153.81B |
| August 05, 2026 | 148.99B |
| August 04, 2026 | 148.16B |
| August 03, 2026 | 157.56B |
| July 31, 2026 | 157.52B |
| July 30, 2026 | 172.68B |
| July 29, 2026 | 172.58B |
| July 28, 2026 | 170.51B |
| July 27, 2026 | 166.19B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 485.50B |
| GSK Plc | 94.16B |
| Johnson & Johnson | 609.11B |
| Eli Lilly & Co. | 1.076T |
| Merck & Co., Inc. | 344.47B |
Market Cap Related Metrics
| PE Ratio | 9.174 |
| PS Ratio | 3.244 |
| PEG Ratio | 0.7281 |
| Price to Book Value | 4.903 |
| Price to Free Cash Flow | 22.20 |
| Price | 37.54 |
| Earnings Yield | 10.90% |
| PEGY Ratio | 0.5277 |
| Operating PE Ratio | 7.148 |
| Normalized PE Ratio | 8.819 |